AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involutionAmy E. Schade, Karen Cichowski, David A. Barbie et al.|Nature|2024Cited by 56
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS <i>-</i> Mutant Colorectal CancersPatrick Loi, Karen Cichowski, Amy E. Schade et al.|Cancer Discovery|2024Cited by 13
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilitiesNaiara Perurena, Karen Cichowski|Cell Reports Medicine|2023Cited by 12
Supplementary Figure S1 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal CancersPatrick Loi, Karen Cichowski, Amy E. Schade et al.|Unknown|2024Cited by 0
Supplementary Figure S6 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal CancersPatrick Loi, Karen Cichowski, Amy E. Schade et al.|Unknown|2024Cited by 0